INVESTIGATIONAL DRUGS: UNMASK THE MYTHS OF COVID-19

*Tanistha Mumtaz Chatterjee, Subham Chakraborty, Dr. Dhrubo Jyoti Sen and Dr. Beduin Mahanti

ABSTRACT

COVID-19: Prevention & Investigational Treatments- COVID-19 is the disease caused by an infection of the SARS-CoV-2 virus, first identified in the city of Wuhan, in China's Hubei province in December 2019. COVID-19 was previously known as 2019 Novel Coronavirus (2019-nCoV) respiratory disease before the World Health Organization (WHO) declared the official name as COVID-19 in February 2020.The SARS-CoV-2 virus belongs to the family of viruses called coronaviruses, which also includes the viruses that cause the common cold, and the viruses that cause more serious infections such as severe acute respiratory syndrome (SARS), which was caused by SARS-CoV in 2002, and Middle East respiratory syndrome (MERS), which was caused by MERS-CoV in 2012. Like the other coronaviruses, the SARS-CoV-2 virus primarily causes respiratory tract infections, and the severity of the COVID-19 disease can range from mild to fatal. Serious illness from the infection is caused by the onset of pneumonia and acute respiratory distress syndrome (ARDS). Currently, there are no FDA approved treatments for COVID-19, and the development of vaccines are still in pipeline.

Keywords: Drug profile, efficacy, clinical research, metabolism, interactions, drug-receptor, inflammatory response, immune complexes.